<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03761368</url>
  </required_header>
  <id_info>
    <org_study_id>RNN/219/13/KE</org_study_id>
    <nct_id>NCT03761368</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Preconditioning and Contrast Induced - Acute Kidney Injury in Patients Undergoing Elective PCI</brief_title>
  <official_title>Remote Ischemic Preconditioning and Contrast Induced - Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention - Randomised Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Lodz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Lodz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized, sham-controlled clinical study was conducted to assess whether RIPC&#xD;
      reduces the incidence of CI-AKI measured standard way of using SCr concentration but also&#xD;
      with the use of serum NGAL as a new potential biomarker of kidney injury. Furthermore, the&#xD;
      aim of investigation was to analyse the safety and clinical outcomes of RIPC after elective&#xD;
      coronary angiography (CA) followed by percutaneous coronary intervention (PCI).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nowadays CI-AKI is defined according to serum creatinine concentration (SCr) as any of the&#xD;
      following: (1) an absolute rise of ≥ 0.5 mg/dL (44 µmol/L) and/or (2) a relative increase of&#xD;
      25% in serum creatinine compared to baseline within 48 to 72 hours after contrast&#xD;
      administration. In the last decades, several novel biomarkers of AKI have been studied&#xD;
      including neutrophil gelatinase-associated lipocalin (NGAL). Furthermore, remote ischemic&#xD;
      preconditioning (RIPC) turned out to be one of the most promising and intriguing&#xD;
      non-pharmacological strategy. This simple procedure consisting of brief, non-lethal episodes&#xD;
      of ischemia and reperfusion applied in one tissue or organ protects remote tissues or organs&#xD;
      from subsequent injury.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2015</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>After admission to the Department, patients were randomly assigned in 1:1 ratio to either control group or RIPC - group by means of a computerized randomization table.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Blinded investigator, not involved in either CA or randomization procedure, performed assignment intervention.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Contrast Induced-Acute Kidney Injury</measure>
    <time_frame>48 to 72 hours after contrast exposure</time_frame>
    <description>absolute rise of ≥ 0.5 mg/dL (44 µmol/L) and/or a relative increase of 25% in serum creatinine compared to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Need of Renal Replacement Therapy</measure>
    <time_frame>up to 7 days after contrast exposure</time_frame>
    <description>qualification for RRT according to standard clinical criteria (level of serum creatinine, serum urea concentration, electrolytes levels (sodium, potassium, chlorides), hydration management)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Presented Cardiogenic Shock</measure>
    <time_frame>up to 7 days after contrast exposure</time_frame>
    <description>sustained hypotension (systolic blood pressure &lt; 90 mm Hg for ≥30 min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death of Any Cause</measure>
    <time_frame>up to one month after contrast exposure</time_frame>
    <description>Number of patients who died.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Remote Ischemic Preconditioning</condition>
  <condition>Contrast Induced - Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>RIPC group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The RIPC group underwent Remote Ischemic Preconditioning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients from control group had sham Remote Ischemic Preconditioning.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote Ischemic Preconditioning</intervention_name>
    <description>four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left upper - arm cuff</description>
    <arm_group_label>RIPC group</arm_group_label>
    <other_name>RIPC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham Remote Ischemic Preconditioning</intervention_name>
    <description>deflated cuff placed on the left arm for 40 min</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Sham RIPC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged over 18 years&#xD;
&#xD;
          -  patients with stable angina pectoris&#xD;
&#xD;
          -  patients admitted to Intensive Cardiac Therapy Clinic Medical University of Lodz with&#xD;
             intention of elective CA with follow-up PCI.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of severe injuries up to 2 months before intervention&#xD;
&#xD;
          -  history of surgeries up to 2 months before intervention&#xD;
&#xD;
          -  history of cancer,&#xD;
&#xD;
          -  acute inflammation during hospitalization&#xD;
&#xD;
          -  chronic autoimmunologic diseases&#xD;
&#xD;
          -  patients needing hemodialysis&#xD;
&#xD;
          -  chronic kidney disease in stage 4 or 5 (eGFR&lt;30 ml/min/1,73m2)&#xD;
&#xD;
          -  peripheral vascular disease affecting upper limbs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marzenna Zielinska, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of Lodz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intensive Cardiac Therapy Clinic</name>
      <address>
        <city>Lodz</city>
        <zip>92-213</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 29, 2018</study_first_submitted>
  <study_first_submitted_qc>November 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2018</study_first_posted>
  <results_first_submitted>June 12, 2020</results_first_submitted>
  <results_first_submitted_qc>October 8, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 30, 2020</results_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Lodz</investigator_affiliation>
    <investigator_full_name>Karolina Stokfisz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>remote ischemic preconditioning</keyword>
  <keyword>contrast induced-acute kidney injury</keyword>
  <keyword>neutrophil gelatinase-associated lipocalin</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>3 years after the end of the study</ipd_time_frame>
    <ipd_access_criteria>on reasonable request</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/68/NCT03761368/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/68/NCT03761368/Prot_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients aged over 18 years presented with stable angina pectoris, admitted to Intensive Cardiac Therapy Clinic Medical University of Lodz and scheduled for elective CA with follow-up PCI.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>RIPC Group</title>
          <description>The RIPC group underwent Remote Ischemic Preconditioning.&#xD;
Remote Ischemic Preconditioning: four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left upper - arm cuff</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Patients from control group had sham Remote Ischemic Preconditioning.&#xD;
Sham Remote Ischemic Preconditioning: deflated cuff placed on the left arm for 40 min</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>RIPC Group</title>
          <description>The RIPC group underwent Remote Ischemic Preconditioning.&#xD;
Remote Ischemic Preconditioning: four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left arm cuff</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Patients from control group had sham Remote Ischemic Preconditioning.&#xD;
Sham Remote Ischemic Preconditioning: deflated cuff placed on the left arm for 40 min</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="101"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="101"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Contrast Medium Intake</title>
          <units>ml</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="100" lower_limit="80" upper_limit="140"/>
                    <measurement group_id="B2" value="110" lower_limit="90" upper_limit="140"/>
                    <measurement group_id="B3" value="110" lower_limit="80" upper_limit="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Serum creatinine on admission</title>
          <units>µmol/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87" lower_limit="81" upper_limit="96"/>
                    <measurement group_id="B2" value="88" lower_limit="82" upper_limit="101"/>
                    <measurement group_id="B3" value="88" lower_limit="81" upper_limit="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NGAL on admission</title>
          <units>ng/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71.3" lower_limit="55.8" upper_limit="86.8"/>
                    <measurement group_id="B2" value="80.6" lower_limit="55.8" upper_limit="101.2"/>
                    <measurement group_id="B3" value="74.4" lower_limit="55.8" upper_limit="102.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Contrast Induced-Acute Kidney Injury</title>
        <description>absolute rise of ≥ 0.5 mg/dL (44 µmol/L) and/or a relative increase of 25% in serum creatinine compared to baseline</description>
        <time_frame>48 to 72 hours after contrast exposure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>The RIPC group underwent Remote Ischemic Preconditioning.&#xD;
Remote Ischemic Preconditioning: four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left upper - arm cuff</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Patients from control group had sham Remote Ischemic Preconditioning.&#xD;
Sham Remote Ischemic Preconditioning: deflated cuff placed on the left arm for 40 min</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Contrast Induced-Acute Kidney Injury</title>
          <description>absolute rise of ≥ 0.5 mg/dL (44 µmol/L) and/or a relative increase of 25% in serum creatinine compared to baseline</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Need of Renal Replacement Therapy</title>
        <description>qualification for RRT according to standard clinical criteria (level of serum creatinine, serum urea concentration, electrolytes levels (sodium, potassium, chlorides), hydration management)</description>
        <time_frame>up to 7 days after contrast exposure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>The RIPC group underwent Remote Ischemic Preconditioning.&#xD;
Remote Ischemic Preconditioning: four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left upper - arm cuff</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Patients from control group had sham Remote Ischemic Preconditioning.&#xD;
Sham Remote Ischemic Preconditioning: deflated cuff placed on the left arm for 40 min</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Need of Renal Replacement Therapy</title>
          <description>qualification for RRT according to standard clinical criteria (level of serum creatinine, serum urea concentration, electrolytes levels (sodium, potassium, chlorides), hydration management)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Presented Cardiogenic Shock</title>
        <description>sustained hypotension (systolic blood pressure &lt; 90 mm Hg for ≥30 min)</description>
        <time_frame>up to 7 days after contrast exposure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>The RIPC group underwent Remote Ischemic Preconditioning.&#xD;
Remote Ischemic Preconditioning: four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left upper - arm cuff</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Patients from control group had sham Remote Ischemic Preconditioning.&#xD;
Sham Remote Ischemic Preconditioning: deflated cuff placed on the left arm for 40 min</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Presented Cardiogenic Shock</title>
          <description>sustained hypotension (systolic blood pressure &lt; 90 mm Hg for ≥30 min)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Death of Any Cause</title>
        <description>Number of patients who died.</description>
        <time_frame>up to one month after contrast exposure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>The RIPC group underwent Remote Ischemic Preconditioning.&#xD;
Remote Ischemic Preconditioning: four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left upper - arm cuff</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Patients from control group had sham Remote Ischemic Preconditioning.&#xD;
Sham Remote Ischemic Preconditioning: deflated cuff placed on the left arm for 40 min</description>
          </group>
        </group_list>
        <measure>
          <title>Death of Any Cause</title>
          <description>Number of patients who died.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>up to one month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>RIPC Group</title>
          <description>The RIPC group underwent Remote Ischemic Preconditioning.&#xD;
Remote Ischemic Preconditioning: four cycles of 5-min inflation to 200 mmHg followed by 5-min deflation of left upper-arm cuff</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Patients from control group had sham Remote Ischemic Preconditioning.&#xD;
Sham Remote Ischemic Preconditioning: deflated cuff placed on the left arm for 40 min</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>skin petechiae</sub_title>
                <description>petechiae on the skin of preconditioned arm distally to upper - arm cuff placement</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Single-center trial.&#xD;
Relatively small sample size.&#xD;
We were unable to observe sufficient number of events, such as CI-AKI, mortality, need for dialysis as an endpoint.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Karolina Stokfisz</name_or_title>
      <organization>Medical University of Łódź</organization>
      <phone>+48422014260</phone>
      <email>stokfisz.karolina@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

